Literature DB >> 8136047

Multiple serotonin mechanisms in animal models of anxiety: environmental, emotional and cognitive factors.

S L Handley1, J W McBlane, M A Critchley, K Njung'e.   

Abstract

Responses to serotonergic drugs in animal models of 'anxiety' are reviewed with emphasis on the elevated X-maze. Evidence for the 'classic' hypothesis, that decreasing serotonergic function is anxiolytic and increasing it anxiogenic, is most consistent in models of behavioural inhibition where the stimulus inhibits an approach response (conflict models). However, paradoxical drug effects are also frequent, especially where the aversive stimulus evokes an active response. Both types of drug effect are equally frequent in the elevated X-maze. 'Anxiety' models may detect multiple sites and mechanisms of action of the same drug; this may indicate multiple anxiety-related neurological mechanisms in the brain. However, not all drug effects in 'anxiety' models are necessarily related to anxiety itself. It is possible that cognitive factors may affect stimulus evaluation, and response inhibition by an aversive stimulus may be a special case of a wider role for serotonin in behavioural control. Clinical implications of these observations are considered.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8136047     DOI: 10.1016/0166-4328(93)90104-x

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  14 in total

1.  (+/-)-1-(2,5-Dimethoxy-4-ethylthiophenyl)-2-aminopropane (ALEPH-2), a novel putative anxiolytic agent lacking affinity for benzodiazepine sites and serotonin-1A receptors.

Authors:  M Reyes-Parada; C Scorza; V Romero; R Silveira; J H Medina; D Andrus; D E Nichols; B K Cassels
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

2.  Strychnine and taurine modulation of amygdala-associated anxiety-like behavior is 'state' dependent.

Authors:  Brian A McCool; Ann Chappell
Journal:  Behav Brain Res       Date:  2007-01-17       Impact factor: 3.332

3.  The dopamine antagonist cis-flupenthixol blocks the expression of the conditioned positive but not the negative effects of cocaine in rats.

Authors:  Jennifer M Wenzel; Zu-In Su; Kerisa Shelton; Hiram M Dominguez; Victoria A von Furstenberg; Aaron Ettenberg
Journal:  Pharmacol Biochem Behav       Date:  2013-09-05       Impact factor: 3.533

4.  Anxiety does not contribute to social withdrawal in the subchronic phencyclidine rat model of schizophrenia.

Authors:  Alexandre Seillier; Andrea Giuffrida
Journal:  Behav Pharmacol       Date:  2017-10       Impact factor: 2.293

Review 5.  Estrogen Receptors Modulation of Anxiety-Like Behavior.

Authors:  A P Borrow; R J Handa
Journal:  Vitam Horm       Date:  2016-10-13       Impact factor: 3.421

Review 6.  Aggression, anxiety and vocalizations in animals: GABAA and 5-HT anxiolytics.

Authors:  K A Miczek; E M Weerts; J A Vivian; H M Barros
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

7.  Maternal profiling of corticotropin-releasing factor receptor 2 deficient mice in association with restraint stress.

Authors:  Kimberly L D'Anna; Sharon A Stevenson; Stephen C Gammie
Journal:  Brain Res       Date:  2008-09-04       Impact factor: 3.252

8.  Bi-directional modulation of bed nucleus of stria terminalis neurons by 5-HT: molecular expression and functional properties of excitatory 5-HT receptor subtypes.

Authors:  J-D Guo; S E Hammack; R Hazra; L Levita; D G Rainnie
Journal:  Neuroscience       Date:  2009-09-22       Impact factor: 3.590

9.  Use of the light/dark test for anxiety in adult and adolescent male rats.

Authors:  Andrew E Arrant; Nicole L Schramm-Sapyta; Cynthia M Kuhn
Journal:  Behav Brain Res       Date:  2013-05-27       Impact factor: 3.332

Review 10.  The response of neurons in the bed nucleus of the stria terminalis to serotonin: implications for anxiety.

Authors:  Sayamwong E Hammack; Ji-Dong Guo; Rimi Hazra; Joanna Dabrowska; Karyn M Myers; Donald G Rainnie
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-05-23       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.